ArticleJournal of hepatocellular carcinoma2026
Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5-10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study.
Article in Journal of hepatocellular carcinoma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to compare long-term oncological outcomes after curative hepatectomy in patients with solitary large versus giant HCC. Patients and Methods: This dual-center study included 281 patients with solitary HCC ≥5 cm undergoing R0 hepatectomy, stratified into large (5-10 cm) and giant (≥10 cm) cohorts. 1:1 PSM matched potential confounding variables. Primary endpoint was recurrence-free survival (RFS), analyzed through Kaplan-Meier methods with Log rank testing. Results: At baseline, giant HCC (n=90) patients exhibited significantly higher rates of AFP ≥200 ng/mL, major hepatectomy, and intraoperative transfusion compared to large HCC (n=191) cohort. After PSM, 82 patients were allocated to each group, with all baseline characteristics well-balanced. The RFS analysis revealed comparable outcomes between large and giant HCC groups: pre-PSM median RFS, 29.6 vs 26.5 months (HR 0.864, 95% CI 0.615-1.214, Conclusion: Patients with solitary giant HCC amenable to upfront curative hepatectomy achieved similar RFS compared to large HCC after surgery, tumor biological characteristics (AFP levels and MVI status) are the primary determinants of postoperative prognosis in HCC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.